Skip to main content

Tissue stem cells as a novel therapeutic strategy for inflammatory disease

Guest edited by Takahiro Ochiya
National Cancer Center Research Institute, Japan

A thematic series in Inflammation and Regeneration.

This series of articles has not been sponsored. All articles have undergone the journal's standard peer review process overseen by the Guest Editor. The Guest Editor declares no competing interests.

  1. The therapeutic effects of mesenchymal stromal/stem cells (MSCs) are mainly based on three characteristics: immunomodulation, tissue regeneration, and hematopoietic support. Cell therapy using culture-expanded...

    Authors: Noriko Sugino, Tatsuo Ichinohe, Akifumi Takaori-Kondo, Taira Maekawa and Yasuo Miura
    Citation: Inflammation and Regeneration 2017 37:7